Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease

NCT02540993 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

5734

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Finerenone (BAY94-8862)
DRUG: Placebo

Sponsor

Bayer